News about "US FDA approves Pfizer-BioNTech vaccine, Comirnaty"

US FDA approves Pfizer-BioNTech vaccine, Comirnaty for prevention of Covid-19 disease in individuals 16 years of age and older

US FDA approves Pfizer-BioNTech vaccine, Comirnaty for prevention of Covid-19 disease in individuals 16 years of age and older

The US Food and Drug Administration (FDA) approved the first covid-19 vaccine. The vaccine has been known as the Pfizer-BioNTech Covid-19 vaccine, and will now be marketed as Comirnaty (koe-mir'-na-tee), for the prevention of Covid-19 disease in individuals 16 years of age and older

US FDA Approves Pfizer-BioNTech Vaccine, Comirnaty | 24/08/2021 | By Darshana 226


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members